US › Healthcare

OSR Holdings Inc (OSRH)

US · Healthcare · Biotechnology

$0.19-7.86%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$315,669

Revenue YoY

-72.2%

Net profit

$-1.0M

Profit YoY

-403.0%

EPS

$-0.02

Net margin

-318.1%

Key statistics

Market cap

$7.1M

Forward P/E

0.0

P/B

0.07

Book value

$2.97

EPS (TTM)

$-0.30

52-week high

$0.91

52-week low

$0.07

50-day MA

$0.35

200-day MA

$0.49

Beta

0.50

Analyst view

with an average price target of $10.00.

Shareholding

Insiders

48.97%

Institutions

1.89%

Largest institutional holders

Fund	Stake
Geode Capital Management, LLC	0.30%
XTX Topco Ltd	0.17%
The Toronto-Dominion Bank	0.11%
Vanguard Capital Management, LLC	0.11%
Vanguard Fiduciary Trust Co	0.05%
StoneX Group Inc	0.04%
Mint Tower Capital Management B.V.	0.02%
UBS Group AG	0.01%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for OSR Holdings Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.